CO “All-Ukrainian Network of People Living with HIV” Potential Problems in Supply – What Can Be Done? Kyiv, 2008.

Slides:



Advertisements
Similar presentations
Diseases without borders What must the Global Development Community Do? World Bank Seminar Series Tawhid Nawaz, Operations Advisor Human Development Network.
Advertisements

National PSM Coordination Mechanism Dr Vincent Habiyambere WHO/HIV Department AIDS Medicines & Diagnostics Service (AMDS) Bangkok, July 2005.
Alessandro de Luca Senior Vice President MERCK Group
CLICK TO ADD TITLE [DATE][SPEAKERS NAMES] The 5th Global Health Supply Chain Summit November , 2012 Kigali, Rwanda Supply Chain Performance Approaches.
Pharmaceuticals Procurement and Supply Management: The case of Ethiopia Cambodia, December 4,
Management of Marketing and Operations 2.2 – Operations
THE CONTEXT OF LOGISTICS. Cycle of Supply and Demand Customers Other Inputs Other Outputs Operations Demand for Products Supply of Products passed to.
Country Ownership for Reproductive Health; An NGO perspectiveSLIDE 1 “ACCESS FOR ALL: SUPPLYING A NEW DECADE FOR REPRODUCTIVE HEALTH ” Country Ownership.
Entrepreneurial Strategy Generating and Exploiting New Strategies
DECENTRALIZATION AND RURAL SERVICES : MESSAGES FROM RECENT RESEARCH AND PRACTICE Graham B. Kerr Community Based Rural Development Advisor The World Bank.
Global Manufacturing and Materials Management
Learning Objectives  Understand the dimensions of organizational structure and how they are important  Select an appropriate business-level structure.
Access to HIV/AIDS, Tuberculosis and Malaria Medicines. WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies. Geneva, 18 – 22 September.
Inventory Management: Distribution, ICS, LMIS Nairobi, 21 February, 2006 Yasmin Chandani HIV/AIDS Technical Coordinator.
Unit 8 Supply Chain. Objectives 1.Describe the special nature of health care commodities due to the need for provider advice and counseling 2.Describe.
The Drug Management Cycle – Distribution
Operations Management Session 25: Supply Chain Coordination.
Essential Medicines Programmes Sudan now Essential Medicines Programmes Sudan now.
12s-1 McGraw-Hill Ryerson Operations Management, 2 nd Canadian Edition, by Stevenson & Hojati Copyright © 2004 by The McGraw-Hill Companies, Inc. All rights.
Procurement and Supply Management in Moldova Laurentiu IONESII.
Copyright © Angler Web Services Angler Technologies Internet-enabled Supply Chain Management ANGLER Strategic Internet.
Slides 6 Distribution Strategies
Introduction to Elements of In-Country Drug Management with Focus on TB Drugs Jim Rankin Director, Center for Pharmaceutical Management Management Sciences.
“The causes of Anti-TB medicines shortages in EMR countries and how to avoid them in the future” Khaled Sultan Drug Management Technical Officer, STOP.
Mark Glaister Procurement Manager Surrey County Council.
CLICK TO ADD TITLE [DATE][SPEAKERS NAMES] The 5th Global Health Supply Chain Summit November , 2012 Kigali, Rwanda Taking Supply Chain Innovations.
Good Anything that can be grown or manufactured (made) Food Clothes Cars.
RHSC Meeting Kampala, May 2010 Quality for Medicines The Global Fund approach Sophie Logez Manager, QA and Data Quality Pharmaceutical Management.
Chapter 3 Supply Organization This is a test.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
Overcoming HIV/AIDS Epidemic in Ukraine National programme supported by GFATM Presentation by Alvaro Bermejo and Andriy Klepikov at the Stakeholders Meeting.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Experience with common basket for ARV procurement Tanzania Emma Lekashingo Msuya.
Non-Governmental Organizations
Chapter 14 Global Production, Outsourcing and Logistics 1.
Bad intentions - good policies: Who wins? Case exercise and role play on drug counterfeiting in an LDC context World Bank Case Exercise – all names and.
Yemaneberhan Taddesse.  PASDEP(plan of accelerated and sustainable development for the Eradication of poverty) Poverty reduction strategy is the main.
Page1 Decentralization of Functions International Conference on Governance and Accountability in Social Sector Decentralization Dana Weist
Overcoming HIV/AIDS Epidemic in Ukraine National programme supported by GFATM.
SCM-INTRODUCTION P.CHANDIRAN. What is a Supply Chain? Supply chain is a network of suppliers, manufacturing plants, warehouses, distribution centers,
From 3by5 to Universal Access to HIV/AIDS Treatment: AMDS Technical Briefing Seminar for Consultants on Procurement and Supply Management for HIV, TB and.
World Health Organization "3 by 5" Target Treat 3 million by 2005.
Quantification of Antimalarials PSM Workshop Nairobi, Kenya February 21, 2006.
Unit 5 Operations Management Location. Learning Objectives To be able to explain the causes and consequences of location and relocation – domestically.
Securing the Supply of Condoms and Other Essential Products for HIV/AIDS Programs Tony Hudgins Yasmin Chandani John Snow Research & Training Institute.
1 SUPPLY DIVISION Procurement and Supply Management Technical Assistance.
Network of Suppliers warehouses, operations, warehouses, distribution centers, retail outlets, and customers. Supply Chain.
Logistics and Supply Chain Management. Introduction to Global Supply Chain Management  What is a Supply Chain ? A system or network consisting of organizations.
Unit 5.4 Location. By the end of the chapter You should be able to …  Explain the reasons for a specific location of production  Discuss the following.
Main Function of SCM (Part I)
Management Information Systems Islamia University of Bahawalpur Delivered by: Tasawar Javed Lecture 3b.
3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.
Page1 Intergovernmental Aspects of Service Delivery Public Expenditure for Human Development Course Dana Weist PRMPS 12 November 2003.
PROCUREMENT & SUPPLY: POOLED PROCUREMENT UKZN IP & Access to Medicines 2009 Professor Brook K. Baker Northeastern U. School of Law Health GAP (Global Access.
State Regulation in the Natural Monopoly Sphere Agency of the Republic of Kazakhstan on Regulation of Natural Monopolies ALMATY – 2006.
Development of Country-Specific Plans for TB Drug Selection and Use China, Brazil, and Indonesia.
Ministry of Health Republic of Indonesia
Chapter 3 Supply Chain Drivers and Obstacles
Production Methods.
Facilities Strategy and Globalization
Current harm reduction program at outreach
BIA 674 – Supply Chain Analytics
Inter-Agency Guidelines for Good Procurement of Pharmaceuticals
World Health Organization
Economics and Work Economic Value of a Good: Concept of a Just Price Human Capital Social Capital as a Means to Decrease Economic Deprivations.
Access to Artemisinin-based Antimalarial Medicines
Chapter 3 Supply Chain Drivers and Obstacles
A Technical Guide to the Contemporary Context and Procurement of HIV/AIDS Medicines and related supplies Case Study Presentation # 7b Duration = 15 min.
Chapter 3 Supply Chain Drivers and Metrics
CHAPTER 11 Organizational Structure and Controls
Presentation transcript:

CO “All-Ukrainian Network of People Living with HIV” Potential Problems in Supply – What Can Be Done? Kyiv, 2008

What Problems? Inappropriate or absent national drug policy Lack of market competition that leads to high prices Quality problems Poor information management that leads to poor forecasting that leads to stock outs or too much stock Fraudulent procurement practices Irrational use of drugs and many others

Where Problems come from? Problems may come from any stage of the supply management cycle. They may come from policies, laws and regulations or They may come from practice

Practical Implications of the Key Decisions Push or Pull Push System is currently used in most of CIS and CE countries Advantages: –Easier quantification and selection decision making process. No need to have skilled procurement staff at local level; –Easier monitoring and control of stock procured and distributed; –In most cases easier control of quality problems, prescription and use practices, which requires less workforce and less sophisticated management information systems

Examples Product selection under the Global Fund grants is done centrally and collegially by the Treatment Working Group taking into account needs of the regional treatment centers. It requires one team of a few people and not 27 teams at every region. Similar function is implemented by the National AIDS Center for the government program Defective batches of goods can be tracked down country-wide and stopped at all regions by one effort of one managing body (Viracept, Duovir case)

Practical Implications of the Key Decisions Push or Pull Disadvantages: –Significant lack of flexibility and inability to efficiently satisfy local needs; –Due to long lead times you have to buy more drugs for doctors to have some choice in prescribing (buffer) that can in the end remain unused if they can’t be returned or exchanged; –Does not stimulate capacity and expertise building at local levels

Examples Hard to satisfy needs of clients of local projects in variety of condoms if centrally you deal with millions of condoms, preferably cheap or donated Hard to fast enough satisfy needs in drugs for emergency, unusual treatment changes or salvage therapy at local treatment centers In ultimate cases doctors are put in a position to prescribe what’s available vs what’s best for the patient

What can be done? Combination of both systems Good reporting system Good Management Information System (MIS) in place – ideally real-time web- based nationwide stock control system Exclude some excessive layers of regulatory control out of the system – for example, distribution orders by MoH for every delivery

Practical Implications of the Key Decisions Centralized vs Decentralized Centralized Advantages: –Similar to Push System – central control and management that requires fewer staff and makes incoming stock more visible –Standard reporting formats and document flow nationwide – easier control and information exchange –Economies of scale and price reduction are possible with a high enough level of centralization –Easier to ensure quality control and quality assurance

Examples Combining orders from different projects we could obtain significant economies of scale and potentially make our markets more attractive to more suppliers (so called pulled procurement) Quality control tests can be performed once at one certified lab on all incoming batches Central procurement body can select quality assured prequalified products from prequalified suppliers

Practical Implications of the Key Decisions Centralized vs Decentralized Disadvantages: –Vulnerability of the whole system to fraudulent practices of the central procurement body –Inappropriate selection of products or suppliers at the central level affects the whole system –Time-consuming, long lead times –Inconvenient for lab reagents or goods, for which sample collection and transportation are required

Examples Selection of unreliable suppliers by a procurement body creates irregularity of supply, which is unacceptable with ARVs Problems with stock outs nationwide if product quality problems are faced (Viracept case, Duovir case)

Practical Implications of the Key Decisions Centralized vs Decentralized Decentralized Advantages: –Flexibility and responsiveness to local needs –Potential quality problems are easier to localize –Builds capacity at local levels

Practical Implications of the Key Decisions Centralized vs Decentralized Decentralized Disadvantages: –Hard to manage. Needs very good MIS and lots of staff –Price variations, at times significant –Impossible economies of scale –Hard to ensure transparency and monitor

What can be done? Combine the two – at local levels use agreements reached at the central level (prime supplier concept), fixed price range and unified quality requirements Examples: –Clinton Foundation agreements –WHO prequalification project

Practical Implications of the Key Decisions Public, Private or NGO Public (and NGOs) practices must be transparent, which makes them highly regulated and sometimes overly regulated Room for corruption NGOs often need to comply with multiple donor requirements Division of functions between public, private and NGO sector within one program creates certain inefficiencies but reduces opportunities for corruption

Practical Implications of the Key Decisions In-house capacity or outsourcing Depends on available capacity. Outsourcing can be a good option and has been used in both GF grants in Ukraine, rather successfully.It could be also a good option for some governments if they lack capacity. Procurement agents used worldwide – IDA, UNICEF Supply Division, WHO AMDS, Missionpharma, etc.

Thank you